$135.42
0[0.00%]
At close: Apr 25
$135.42
0[0.00%]
PreMarket: 4:00PM EDT
Quest Diagnostics
(NYSE:DGX)Latest News for Quest Diagnostics Stock (NYSE:DGX)
Quest Diagnostics Stock (NYSE: DGX)
Categories: All
Thursday, April 25, 2024
Wednesday, April 24, 2024
- Peering Into Quest Diagnostics's Recent Short InterestBenzinga Insights - 1 day ago
- Citigroup Maintains Neutral on Quest Diagnostics, Raises Price Target to $145Benzinga Newsdesk - 1 day ago
- UBS Maintains Neutral on Quest Diagnostics, Raises Price Target to $146Benzinga Newsdesk - 1 day ago
- Truist Securities Maintains Hold on Quest Diagnostics, Raises Price Target to $150Benzinga Newsdesk - 2 days ago
- The Analyst Landscape: 5 Takes On Quest DiagnosticsBenzinga Insights - 2 days ago
- Mizuho Maintains Buy on Quest Diagnostics, Raises Price Target to $155Benzinga Newsdesk - 2 days ago
Tuesday, April 23, 2024
- Quest Diagnostics Says Sales In Q1 Increased For The First Time Since The Height Of PandemicVandana Singh - 2 days ago
- Quest Diagnostics shares are trading higher after the company reported a Q1 earnings beat and raised its 2024 guidance.Benzinga Newsdesk - 3 days ago
- Earnings Scheduled For April 23, 2024Benzinga Insights - 3 days ago
- Quest Diagnostics Forecasts FY2024 Adjusted EPS Of $8.72-$8.97 Versus Prior Guidance Of $8.60-$8.90 And Consensus Of $8.75Benzinga Newsdesk - 3 days ago
- Quest Diagnostics Expects FY2024 Revenues Of $9.4B-$9.48B Versus Prior Guidance Of $9.35B-$9.45B And Consensus Of $9.40BBenzinga Newsdesk - 3 days ago
- Quest Diagnostics Q1 2024 Adj EPS $2.04 Beats $1.86 Estimate, Sales $2.366B Beat $2.287B EstimateBenzinga Newsdesk - 3 days ago
Monday, April 22, 2024
- Quest Diagnostics Adds p-tau217 Blood Biomarker Testing To Suite Of Services Designed To Assess Risk And Help Aid Diagnosis Of Alzheimer's DiseaseBenzinga Newsdesk - 4 days ago
- US Stocks Set To Open Fresh Week Higher On Big Tech Earnings Hopes: Analyst Warns Any Letdown Could Push Market 'Deeper Into Oversold Territory'Shanthi Rexaline - 4 days ago
Sunday, April 21, 2024
Wednesday, March 20, 2024
Monday, March 18, 2024
Tuesday, March 05, 2024
Monday, February 26, 2024
Wednesday, February 21, 2024
Tuesday, February 13, 2024
Wednesday, February 07, 2024
Friday, February 02, 2024
Thursday, February 01, 2024
- Quest Diagnostics Sees Fiscal 2024 Revenues Of $9.35B-$9.45B And Adjusted EPS Of $8.60-$8.90, Compared To Consensus Of $9.38B And $8.97, RespectivelyBenzinga Newsdesk - Feb 1, 2024, 6:56AM
- Quest Diagnostics Has Authorized A 5.6% Increase In Its Quarterly Dividend From $0.71 To $0.75 Per Share, Or $3.00 Per Share Annually, Effective With The Dividend Payable On April 22, With Record Date Of April 8Benzinga Newsdesk - Feb 1, 2024, 6:51AM
- Quest Diagnostics Q4 Adjusted EPS $2.15 Beats $2.11 Estimate, Sales $2.29B Beat $2.25B EstimateBenzinga Newsdesk - Feb 1, 2024, 6:49AM
- Earnings Scheduled For February 1, 2024Benzinga Insights - Feb 1, 2024, 5:03AM
- Investor Sentiment Falls Sharply Following Fed's Rate Decision; Dow Dips Over 300 PointsAvi Kapoor - Feb 1, 2024, 4:40AM
- Quest Diagnostics Likely To Report Higher Q4 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate AnalystsAvi Kapoor - Feb 1, 2024, 1:23AM
Wednesday, January 31, 2024
Wednesday, January 17, 2024
Friday, January 12, 2024
Tuesday, January 09, 2024
Monday, January 08, 2024
Tuesday, January 02, 2024
Wednesday, December 20, 2023
Tuesday, December 19, 2023
Wednesday, December 13, 2023
Tuesday, December 12, 2023
Monday, December 11, 2023
Thursday, December 07, 2023
- Universal DX Announces The Initial Closing Of Its Series B Financing Of Approximately $70M With Investors, Including Quest DiagnosticsBenzinga Newsdesk - Dec 7, 2023, 1:57PM
- Expert Ratings for Quest DiagnosticsBenzinga Insights - Dec 7, 2023, 12:00PM
- UBS Maintains Neutral on Quest Diagnostics, Raises Price Target to $137Benzinga Newsdesk - Dec 7, 2023, 11:25AM
- Quest Diagnostics And CDC Expand Public Health Research Collaboration To Better Understand Hepatitis C Burden In The United StatesBenzinga Newsdesk - Dec 7, 2023, 8:06AM